Actinium Pharmaceuticals Inc Pivotal Phase 3 SIERRA Trial Call Transcript
Welcome to the Actinium Pharmaceuticals conference call. (Operator Instructions). As a reminder, this conference is being recorded Monday, August (sic - October) 28, 2019. I would now like to turn the conference over to your host, Mr. Steve O'Loughlin, Actinium's Principal Financial Officer. Please go ahead.
' -
Thank you, operator. Before we begin I would like to go over the disclaimer and Safe Harbor statement. Some of the information presented herein may contain projections or other forward-looking statements regarding future events or the future financial performance of the Company, which the Company undertakes no obligation to update.
These statements are based on management's current expectations and are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with preliminary study results varying from final results; estimates of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
